Kenneth Lynn has legal, executive and board-level experience with a variety of private and publicly traded biopharmaceutical and telecommunications companies, including United Telecom Computer Group, Marion Merrill Dow, U.S. Bioscience, Cortech, Valentis and NewLink Genetics Corporation. He has held executive-level positions with the Kansas Technology Enterprise Corporation and Ewing Marion Kauffman Foundation, which work to foster innovation and grow the local technology sector. Lynn currently consults and advises companies and organizations in the technology and biopharmaceutical industries. He launched his own specialty product manufacture start-up venture in 2014.
- Transactional LawMeet
M.B.A., Rockhurst University, 1990.
J.D., University of Kansas, 1981.